Damora Therapeutics - (DMRA) closed at $24.07 on November 9, 2026, up 1.6% from the previous close, on volume of 535,596 shares (30-day average 465,565).
Data as of November 9, 2026.
Damora Therapeutics (DMRA) Receives a Buy from Wedbush
TipRanks (Fri, 6-Nov 2:17 AM ET)
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire (Thu, 5-Nov 4:01 PM ET)
RBC Capital Sticks to Their Buy Rating for Damora Therapeutics (DMRA)
TipRanks (Thu, 5-Nov 7:37 AM ET)
H.C. Wainwright Keeps Their Buy Rating on Damora Therapeutics (DMRA)
TipRanks (Thu, 5-Nov 7:16 AM ET)
Damora Therapeutics Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights
Globe Newswire (Wed, 4-Nov 4:06 PM ET)
Globe Newswire (Wed, 4-Nov 9:00 AM ET)
Damora Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
Globe Newswire (Mon, 10-Aug 4:05 PM ET)
Damora Therapeutics Sets Sights on Clinical Milestones for Groundbreaking mutCALR Therapies in 2026
Market Chameleon (Wed, 13-May 4:46 AM ET)
Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.
Damora Therapeutics - trades on the NASDAQ stock market under the symbol DMRA.
As of November 10, 2026, DMRA stock price climbed to $24.49 with 29,852 million shares trading.
DMRA has a beta of 0.21, meaning it tends to be less sensitive to market movements. DMRA has a correlation of 0.00 to the broad based SPY ETF.
DMRA has a market cap of $1.52 billion. This is considered a Small Cap stock.
The top ETF exchange traded funds that DMRA belongs to (by Net Assets): IWM, XBI, VXF, IWO, SCHA.
DMRA support price is $22.88 and resistance is $25.26 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DMRA shares will trade within this expected range on the day.
